|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.46 USD | -1.52% |
|
+4.32% | -29.15% |
| Dec. 12 | Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating | MT |
| Dec. 12 | Rate Cuts Can't Buy Confidence |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MODERNA, INC. | Biopharmaceuticals | -1.47% | +4.32% | -29.15% | -29.59% | -78.50% | 11.69B |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- MRNA Stock
- Charts Moderna, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
